US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist

8.780
+0.910+11.56%

Close Nov 22 16:00 ET

8.780
0.0000.00%

Post 20:02 ET

503.08MMarket Cap-3850P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Olema Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Olema Pharmaceuticals Earnings Reports

Olema Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:22 ET

Olema Pharmaceuticals | 8-K: Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 16:16 ET

Olema Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 6 16:20 ET

Olema Pharmaceuticals | 8-K: Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 6 16:18 ET

Analyst Rating

Updated: Nov 21, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall